Reproduction permitted for personal use only. For reprints and reprint permission, contact firstname.lastname@example.org.
Jeff Johnson, a UW-Madison scientist, and his colleagues want to develop a commercial drug for Alzheimer's disease at their new company in Madison, named Mithridion. Also, Wisconsin legislators are introducing a new computer privacy law aimed at making companies notify people of database breaches, and the UW's Science Expeditions will be open to the public April 2.
Original air date: Saturday, March 26, 2005